<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/321463</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;321463</article-id><article-id pub-id-type="other" hwp:sub-type="slug">321463</article-id><article-id pub-id-type="other" hwp:sub-type="tag">321463</article-id><article-version>1.1</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Systems Biology" hwp:journal="biorxiv"><subject>Systems Biology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Estimating parasite load dynamics to reveal novel resistance mechanisms to human malaria</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label>Corresponding author: <email hwp:id="email-1">a.cunnington@imperial.ac.uk</email> (AJC)</corresp><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2 xref-fn-1-3"><label>#</label><p hwp:id="p-1">Denotes equal contribution</p></fn><fn id="n3" fn-type="present-address" hwp:id="fn-2" hwp:rev-id="xref-fn-2-1"><label>b</label><p hwp:id="p-2">Current address: Untere Grabenstraße 10, 88299 Leutkirch, Germany</p></fn><fn id="n2" fn-type="equal" hwp:id="fn-3" hwp:rev-id="xref-fn-3-1"><label>a</label><p hwp:id="p-3">MTB performed the work related to this publication at Imperial College and is now an employee of F. Hoffmann-La Roche Ltd.</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Bretscher Michael T."><surname>Bretscher</surname><given-names>Michael T.</given-names></name><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">#</xref><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-3-1" hwp:rel-id="fn-3">a</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Georgiadou Athina"><surname>Georgiadou</surname><given-names>Athina</given-names></name><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">#</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Lee Hyun Jae"><surname>Lee</surname><given-names>Hyun Jae</given-names></name><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-3" hwp:rel-id="fn-1">#</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Walther Michael"><surname>Walther</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref><xref ref-type="fn" rid="n3" hwp:id="xref-fn-2-1" hwp:rel-id="fn-2">b</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="van Beek Anna E."><surname>van Beek</surname><given-names>Anna E.</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Fitriani Fadlila"><surname>Fitriani</surname><given-names>Fadlila</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Wouters Diana"><surname>Wouters</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-2" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Kuijpers Taco W."><surname>Kuijpers</surname><given-names>Taco W.</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Nwakanma Davis"><surname>Nwakanma</surname><given-names>Davis</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="D’Alessandro Umberto"><surname>D’Alessandro</surname><given-names>Umberto</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-3" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Riley Eleanor M."><surname>Riley</surname><given-names>Eleanor M.</given-names></name><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-1" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Levin Michael"><surname>Levin</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Coin Lachlan J."><surname>Coin</surname><given-names>Lachlan J.</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="Ghani Azra"><surname>Ghani</surname><given-names>Azra</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><name name-style="western" hwp:sortable="Conway David J."><surname>Conway</surname><given-names>David J.</given-names></name><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-1" hwp:rel-id="aff-10">10</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-16"><name name-style="western" hwp:sortable="Cunnington Aubrey J."><surname>Cunnington</surname><given-names>Aubrey J.</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-4" hwp:rel-id="aff-2">2</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>1</label><institution hwp:id="institution-1">Medical Research Council Centre for Outbreak Analysis and Modelling, Imperial College</institution>, London, <country>United Kingdom</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3 xref-aff-2-4"><label>2</label><institution hwp:id="institution-2">Section of Paediatrics, Imperial College</institution>, London, <country>United Kingdom</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2"><label>3</label><institution hwp:id="institution-3">Institute for Molecular Bioscience, University of Queensland</institution>, Brisbane, <country>Australia</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2 xref-aff-4-3"><label>4</label><institution hwp:id="institution-4">MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine</institution>, Fajara, <country>The Gambia</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1 xref-aff-5-2"><label>5</label><institution hwp:id="institution-5">Department of Immunopathology, Sanquin Research and Landsteiner Laboratory of the Academic Medical Centre, University of Amsterdam</institution>, Amsterdam, <country>the Netherlands</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2"><label>6</label><institution hwp:id="institution-6">Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children’s Hospital, Academic Medical Centre</institution>, Amsterdam, <country>the Netherlands</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1"><label>7</label><institution hwp:id="institution-7">Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory of the Academic Medical Centre, University of Amsterdam</institution>, Amsterdam, <country>the Netherlands</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1"><label>8</label><institution hwp:id="institution-8">The Roslin Institute and the Royal (Dick) School of Veterinary Studies, University of Edinburgh</institution>, Edinburgh, <country>United Kingdom</country></aff><aff id="a9" hwp:id="aff-9" hwp:rev-id="xref-aff-9-1"><label>9</label><institution hwp:id="institution-9">Department of Immunology and Infection, London School of Hygiene and Tropical Medicine</institution>, London, <country>United Kingdom</country></aff><aff id="a10" hwp:id="aff-10" hwp:rev-id="xref-aff-10-1"><label>10</label><institution hwp:id="institution-10">Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine</institution>, <country>United Kingdom</country></aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2018"><year>2018</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-05-15T08:33:13-07:00">
    <day>15</day><month>5</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2018-05-15T08:33:13-07:00">
    <day>15</day><month>5</month><year>2018</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-05-15T08:39:21-07:00">
    <day>15</day><month>5</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2018-05-15T08:39:21-07:00">
    <day>15</day><month>5</month><year>2018</year>
  </pub-date><elocation-id>321463</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-05-13"><day>13</day><month>5</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2018-05-13"><day>13</day><month>5</month><year>2018</year></date>
<date date-type="accepted" hwp:start="2018-05-15"><day>15</day><month>5</month><year>2018</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2018</copyright-year><license hwp:id="license-1"><p hwp:id="p-4">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="321463.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/321463v1.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="321463.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/321463v1/321463v1.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/321463v1/321463v1.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-5">Improved methods are needed to identify host mechanisms which directly protect against human infectious diseases in order to develop better vaccines and therapeutics<sup><xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>,<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref></sup>. Pathogen load determines the outcome of many infections<sup><xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref></sup>, and is a consequence of pathogen multiplication rate, duration of the infection, and inhibition or killing of pathogen by the host (resistance). If these determinants of pathogen load could be quantified then their mechanistic correlates might be determined. In humans the timing of infection is rarely known and treatment cannot usually be withheld to monitor serial changes in pathogen load and host response. Here we present an approach to overcome this and identify potential mechanisms of resistance which control parasite load in <italic toggle="yes">Plasmodium falciparum</italic> malaria. Using a mathematical model of longitudinal infection dynamics for orientation, we made individualized estimates of parasite multiplication and growth inhibition in Gambian children at presentation with acute malaria and used whole blood RNA-sequencing to identify their correlates. We identified novel roles for secreted proteases cathepsin G and matrix metallopeptidase 9 (MMP9) as direct effector molecules which inhibit <italic toggle="yes">P. falciparum</italic> growth. Cathepsin G acts on the erythrocyte membrane, cleaving surface receptors required for parasite invasion, whilst MMP9 acts on the parasite. In contrast, the type 1 interferon response and expression of <italic toggle="yes">CXCL10</italic> (IFN-γ-inducible protein of 10 kDa, IP-10) were detrimental to control of parasite growth. Natural variation in iron status and plasma levels of complement factor H were determinants of parasite multiplication rate. Our findings demonstrate the importance of accounting for the dynamic interaction between host and pathogen when seeking to identify correlates of protection, and reveal novel mechanisms controlling parasite growth in humans. This approach could be extended to identify additional mechanistic correlates of natural- and vaccine-induced immunity to malaria and other infections.</p></abstract><counts><page-count count="48"/></counts></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">Main Text</title><p hwp:id="p-6">To heuristically estimate the hidden dynamics of parasite load (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig 1a</xref>) in naturally-infected malaria patients we calibrated a statistical prediction model using outputs from a mechanistic simulation which combined information from two datasets (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig 1b</xref>). A historical dataset of the longitudinal course of infection in patients who were deliberately inoculated with <italic toggle="yes">P. falciparum</italic> as a treatment for neurosyphilis (malariatherapy) (<xref ref-type="fig" rid="figE1" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Extended Data Figure 1</xref>) was used as a reference for changes in parasite load over time<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref></sup>. In this dataset, relationships were defined between measured and latent variables (which we assume to determine changes in parasite load over time), broadly based on a mathematical model proposed by Dietz et al.<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-2" hwp:rel-id="ref-4">4</xref></sup>. Measurements from Gambian children with malaria at the time of clinical presentation (<xref ref-type="table" rid="tblE1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Extended Data Table 1</xref>) were then used to estimate the values of the latent variables and dynamics of parasite load in individual children.</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5 xref-fig-1-6 xref-fig-1-7"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig 1.</label><caption hwp:id="caption-1"><title hwp:id="title-3">Estimating the dynamics of parasite load and host response in malaria.</title><p hwp:id="p-7">(<bold>a, b</bold>) Conceptual models of the major determinants of parasite load (<bold>a</bold>) and a framework for use of measurable variables at a single point in time (parasite load, duration of illness, plasma TNF, blue lines) to estimate latent variables (<italic toggle="yes">m</italic> and <italic toggle="yes">P<sub>c</sub></italic>, red lines) (<bold>b</bold>). (<bold>c</bold>) Simulated relationships between <italic toggle="yes">P<sub>c</sub>, m</italic>, parasite biomass, duration of illness and TNF concentrations in Gambian children. (<bold>d-i</bold>) Comparisons of parasite biomass (<bold>d</bold>), TNF (<bold>e</bold>), predicted <italic toggle="yes">m</italic> (<bold>f</bold>), predicted <italic toggle="yes">P<sub>c</sub></italic> (<bold>g</bold>), duration of illness (<bold>h</bold>), and predicted parasite growth inhibition (PGI, <bold>i</bold>), in 139 Gambian children with uncomplicated (UM, <italic toggle="yes">n</italic> =64) or severe malaria (SM1, prostration, <italic toggle="yes">n</italic> =36; SM2, any combination of cerebral malaria, hyperlactatemia or severe anemia, <italic toggle="yes">n</italic> =39). Boxes show median and interquartile range, whiskers extend 1.5-times the interquartile range or to limit of range; <italic toggle="yes">P</italic> for ANOVA (above plots), and for Mann-Witney test (UM vs SM2, within plots). (<bold>j, k</bold>) Correlation of predicted <italic toggle="yes">m</italic> (<bold>j</bold>) or <italic toggle="yes">P<sub>c</sub></italic> (<bold>k</bold>) with age (blue line, linear regression; shaded area 95% confidence interval), <italic toggle="yes">P</italic> for Pearson correlation.</p></caption><graphic xlink:href="321463_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-8">In our model, ascending parasite load dynamics (up to the first peak) in the malariatherapy reference data can be largely described with two individual-specific latent variables (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig 1a</xref>, see Methods): the within-host multiplication rate, <italic toggle="yes">m</italic>, which is the initial rate of increase in parasite load before any constraint by the host response; and <italic toggle="yes">P<sub>c</sub></italic>, which is defined by the parasite load required to stimulate a host response that reduces parasite growth by 50%<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-3" hwp:rel-id="ref-4">4</xref></sup>. When <italic toggle="yes">m, P<sub>c</sub></italic>, and parasite load are known, the parasite growth inhibition (PGI) by the host response at that point in time can be calculated. We determined the relationships between ascending parasite load, onset of fever, <italic toggle="yes">m</italic>, and <italic toggle="yes">P<sub>c</sub></italic> and their inter-individual variation in 97 malariatherapy subjects in the reference dataset. We then sought the best fit for the distribution of these parameters and their inter-relationships to explain parasite load and duration of illness at the time of presentation using data from 139 Gambian children with malaria (<xref ref-type="table" rid="tblE1" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Extended Data Table 1</xref>). To provide an additional point of reference we assumed that plasma TNF concentration in the Gambian children should be related to the intensity of the protective host response because this cytokine has been shown to augment parasite growth inhibition by human cells<sup><xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>,<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref></sup>. The optimal relationship between TNF and growth inhibition was determined using a maximum-likelihood approach (see <xref ref-type="fig" rid="figS1" hwp:id="xref-fig-8-1" hwp:rel-id="F8">Methods and Supplementary Figure 1</xref>). Other model assumptions and definitions are shown in <xref ref-type="table" rid="tblE2" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Extended Data Table 2</xref>. To accommodate biological variation between Gambian children and adult malariatherapy subjects we allowed parameters to be rescaled to improve the fit between the two datasets, resulting in <italic toggle="yes">P<sub>c</sub></italic> values in the Gambian children being higher than those in the malariatherapy subjects (see Methods). This implies that Gambian children required a higher parasite load than the adult malariatherapy subjects to stimulate a similar host response and is consistent with epidemiological data showing higher fever thresholds in <italic toggle="yes">P. falciparum</italic> infected children than in adults<sup><xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref></sup>.</p><p hwp:id="p-9">After defining the relationships between parasite load, duration of fever, TNF concentration, <italic toggle="yes">m</italic>, and <italic toggle="yes">P<sub>c</sub></italic> for the Gambian dataset as a whole (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Figure 1c</xref>), we predicted values of <italic toggle="yes">m</italic> and <italic toggle="yes">P<sub>c</sub></italic> for individual Gambian children based on their measured parasite load and plasma TNF concentration and their reported duration of fever (<xref ref-type="table" rid="tblE3" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Extended Data Table 3</xref>). Parasite load, TNF, predicted <italic toggle="yes">m</italic>, and predicted <italic toggle="yes">P<sub>c</sub></italic> values were highest in those with the most severe manifestations of malaria (SM2), intermediate in those with prostration as the only manifestation of severe disease (SM1), and lowest in uncomplicated malaria (UM) (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig 1d-g</xref>). Duration of illness and estimated PGI at the time of presentation did not differ significantly by clinical phenotype (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-6" hwp:rel-id="F1">Fig 1h-i</xref>).</p><p hwp:id="p-10">Since age can be a major determinant of malaria severity and naturally acquired immunity<sup><xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>,<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref></sup>, we examined whether age was associated with <italic toggle="yes">m</italic> or <italic toggle="yes">P<sub>c</sub></italic>. In this population age was not significantly correlated with <italic toggle="yes">m</italic> but was significantly negatively correlated with <italic toggle="yes">P<sub>c</sub></italic> (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-7" hwp:rel-id="F1">Fig 1j-k</xref>). This implies little age-related acquisition of constitutive resistance (for example, naturally-acquired antibody-mediated immunity) in children in this region of The Gambia, which might be expected from the relatively low malaria transmission<sup><xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>,<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref></sup>. However, these data also indicate that a lower parasite load should be needed to generate an equivalent protective host response to parasites in older individuals.</p><p hwp:id="p-11">To determine whether our model-derived estimates could be used to aid discovery of mechanistic correlates of resistance to <italic toggle="yes">P. falciparum</italic> we performed RNA sequencing on whole blood collected from 23 of the subjects (13 with UM, 10 with SM, <xref ref-type="table" rid="tblE4" hwp:id="xref-table-wrap-4-1" hwp:rel-id="T4">Extended Data Table 4</xref>) at time of presentation. To avoid confounding by differences in the proportions of major leukocyte subpopulations we performed gene signature-based deconvolution and adjusted total gene expression for cell-mixture. 51 human genes were significantly correlated (26 positively, 25 negatively) with the estimated PGI after adjustment for false discovery rate. We reasoned that these genes should be enriched for effector mechanisms which control parasite load <italic toggle="yes">in vivo</italic>. The positively correlated genes (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig 2a</xref>), associated with enhanced control of parasite growth, showed limited canonical pathway enrichments (<xref ref-type="table" rid="tblE5" hwp:id="xref-table-wrap-5-1" hwp:rel-id="T5">Extended Data Table 5</xref>) but 16 (62%) were linked together in a network around extracellular signal-regulated kinases ERK1/2 and AKT serine/threonine kinase (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig 2b</xref>). These kinases integrate cellular inflammatory and metabolic responses to control innate defence mechanisms such as cytokine secretion, phagocytosis and degranulation<sup><xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>,<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref></sup>. The 25 genes negatively correlated with PGI (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig 2c</xref>), associated with poorer control of parasite growth, were strongly enriched in immune response pathways (<xref ref-type="table" rid="tblE5" hwp:id="xref-table-wrap-5-2" hwp:rel-id="T5">Extended Data Table 5</xref>). Network analysis showed 15 (60%) of the negatively correlated genes were linked through a network focussed around type 1 interferon (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Fig 2d</xref>). These findings are consistent with observations that sustained type 1 interferon signalling can impair control of parasite load in mice<sup><xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>–<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref></sup> and potentially in humans<sup><xref ref-type="bibr" rid="c14" hwp:id="xref-ref-14-2" hwp:rel-id="ref-14">14</xref>,<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref></sup>. C-X-C motif chemokine ligand 10 (CXCL10, also known as IFN-γ-inducible protein of 10 kDa, IP-10) expression had the greatest log-fold change of the genes negatively correlated with PGI (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-5" hwp:rel-id="F2">Fig 2c</xref>), consistent with findings that CXCL10 expression impairs control of parasite load in mice<sup><xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref></sup>.</p><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4 xref-fig-2-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig 2.</label><caption hwp:id="caption-2"><title hwp:id="title-4">Transcriptional correlates of parasite growth inhibition</title><p hwp:id="p-12">(<bold>a, b</bold>) Genes significantly positively correlated with parasite growth inhibition (ie. predicted to reduce parasite growth) after adjustment for false discovery (<bold>a</bold>) and primary network derived from these genes (<bold>b</bold>). (<bold>c, d</bold>) Genes significantly negatively correlated with parasite growth inhibition (predicted to increase parasite growth) after adjustment for false discovery (<bold>c</bold>), and primary network derived from these genes (<bold>d</bold>).</p></caption><graphic xlink:href="321463_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-13">None of the genes positively correlated with PGI have previously been described as mediators of resistance to malaria so we sought direct biological evidence, focussing on genes encoding secreted proteins as the best candidates. Of the 26 genes, two encode predominantly secreted proteins: <italic toggle="yes">CTSG</italic> (cathepsin G) and <italic toggle="yes">MMP9</italic> (matrix metallopeptidase 9, also known as gelatinase B). Cathepsin G localizes in neutrophil azurophil granules whilst MMP9 localises in neutrophil gelatinase and specific granules<sup><xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref></sup>. Treatment with recombinant cathepsin G and MMP9 inhibited growth of <italic toggle="yes">P. falciparum</italic> 3D7 strain <italic toggle="yes">in vitro</italic> (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig 3a</xref>). In order to elucidate mechanisms of action we examined whether these proteases inhibited parasite growth by preventing invasion of erythrocytes. Addition of cathepsin G to schizont cultures produced a dramatic reduction in invasion, and pretreatment of erythrocytes with cathepsin G before adding them to schizont cultures produced a similar reduction in their invasion (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig 3b</xref>), indicating that cathepsin G acts primarily on the erythrocyte (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig 3b</xref>). Addition of MMP9 to schizont cultures produced a more modest reduction, whilst pretreatment of erythrocytes did not reduce invasion, implying that MMP9 likely acts against schizonts or free merozoites rather than preventing invasion at the erythrocyte surface (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-4" hwp:rel-id="F3">Fig 3b</xref>).</p><p hwp:id="p-14">In order to identify biologically relevant concentrations of cathepsin G and MMP9 we measured their concentrations in whole blood from healthy donors, before and after degranulation was stimulated with PMA, and in plasma from children with malaria at the time of clinical presentation (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-5" hwp:rel-id="F3">Fig 3c</xref>). Local concentrations which might occur <italic toggle="yes">in vivo</italic>, adjacent to degranulating neutrophils, could be at least an order of magnitude higher<sup><xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref></sup>. MMP9 dose-dependently inhibited parasite growth over a physiological range of concentrations (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-6" hwp:rel-id="F3">Fig 3d</xref>). Similarly, parasite invasion was dose-dependently inhibited by cathepsin G pre-treatment of erythrocytes, with similar effects in each of four parasite strains with different invasion phenotypes<sup><xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref></sup> (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-7" hwp:rel-id="F3">Fig 3e</xref>). We therefore asked whether cathepsin G might cleave a range of RBC surface proteins which are used as invasion receptors by <italic toggle="yes">P. falciparum</italic> <sup><xref ref-type="bibr" rid="c24" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref></sup>. Consistent with its broad inhibition of parasite invasion, cathepsin G dose-dependently cleaved the majority of <italic toggle="yes">P. falciparum</italic> invasion receptors including glycophorins A, B, and C, CD147 (basigin), CD108 (semaphorin 7A), and complement receptor 1 (CR1), but not CD55 (DAF) (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-8" hwp:rel-id="F3">Fig 3f</xref>). MMP9 did not cleave any of these surface receptors (<xref ref-type="fig" rid="figE2" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Extended Data Figure 2</xref>). PMA stimulation of healthy donor whole blood recapitulated the loss of erythrocyte surface glycophorins A and B, CD108 and CD147 in all donors, decreased glycophorin C expression in 6 of 8 healthy donors, but did not consistently reduce CR1 (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-9" hwp:rel-id="F3">Fig 3g</xref>) (as might be expected from the dose-response curves, <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-10" hwp:rel-id="F3">Fig 3f</xref>). In samples from Gambian children on the day of presentation with <italic toggle="yes">P. falciparum</italic> malaria, the proportions of erythrocytes with detectable expression of glycophorins A and B and CD147 were significantly lower than in convalescent samples (28 days after treatment), and there was a trend to lower expression of CD108 and glycophorin C (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-11" hwp:rel-id="F3">Fig 3h</xref>). These results would be consistent with cleavage of these surface molecules <italic toggle="yes">in vivo</italic> during acute infection. The variable expression seen at day 28 (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-12" hwp:rel-id="F3">Fig 3h</xref>) may indicate the persistence of modified erythrocytes in the circulation. The importance of glycophorins and basigin in RBC invasion and genetic susceptibility to severe malaria is well established<sup><xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>–<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref></sup>, and so it is highly likely that the cleavage of these erythrocyte receptors by cathepsin G would have a protective effect <italic toggle="yes">in vivo</italic>.</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3 xref-fig-3-4 xref-fig-3-5 xref-fig-3-6 xref-fig-3-7 xref-fig-3-8 xref-fig-3-9 xref-fig-3-10 xref-fig-3-11 xref-fig-3-12"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig 3.</label><caption hwp:id="caption-3"><title hwp:id="title-5">Effects of cathepsin G and MMP9 on parasite growth and expression of erythrocyte invasion receptors</title><p hwp:id="p-15">(<bold>a</bold>) Effect of cathepsin G (18µg/mL) and MMP9 (16µg/mL) on <italic toggle="yes">in vitro</italic> growth (n=3–8 biological replicates, representative of two independent experiments). (<bold>b</bold>) Effect of cathepsin G (18µg/mL) and MMP9 (18µg/mL) on erythrocyte invasion of <italic toggle="yes">P. falciparum</italic> 3D7 when added directly to schizonts and donor red cells, or when pre-incubated (PT) with donor red cells before washing and adding to schizonts (n=3 biological replicates per condition, representative of two independent experiments). (<bold>a</bold>,<bold>b</bold>) Show mean (95% CI) and <italic toggle="yes">P</italic> for unpaired t-test. (<bold>c</bold>) Cathepsin G and MMP9 concentrations in plasma from healthy donor whole blood (n=8) unstimulated or stimulated with 1µM PMA, and from Gambian children with <italic toggle="yes">P. falciparum</italic> malaria (n=34). Bars show median, <italic toggle="yes">P</italic> for Wilcoxon matched pairs test. (<bold>d, e</bold>) Dose response for growth inhibition by MMP9 against <italic toggle="yes">P. falciparum</italic> 3D7 and (<bold>d</bold>) and for invasion inhibition using cathepsin G pre-treated RBCs against four parasite strains (n=3 biological replicates per dose, mean (95% CI) and <italic toggle="yes">P</italic> for linear trend, representative of two independent experiments). (<bold>f</bold>) Dose response for erythrocyte surface receptor cleavage by cathepsin G (n=3 biological replicates per dose, mean +/- standard error, asymmetric 5-parameter logistic regression fit lines, representative of two experiments). (<bold>g</bold>) Effect of PMA stimulation of healthy donor (n=8) whole blood on erythrocyte surface receptor expression assessed by fluorescence intensity (<italic toggle="yes">P</italic> for Wilcoxon matched pairs test). (<bold>h</bold>) Comparison of proportion of erythrocytes with detectable receptor expression in acute (day 0) and convalescent (day 28) samples from Gambian children with malaria (n=6, <italic toggle="yes">P</italic> for one-sided Wilcoxon test).</p></caption><graphic xlink:href="321463_fig3" position="float" orientation="portrait" hwp:id="graphic-3"/></fig><p hwp:id="p-16">Having shown that mechanisms of host resistance can be identified from their correlation with PGI, we asked whether we could also identify mechanisms controlling <italic toggle="yes">m</italic>. In our model, <italic toggle="yes">m</italic> may be influenced by constitutive factors but should be independent of any parasite load-dependent host response. Therefore we sought to confirm expected associations with two constitutive host factors known to influence parasite growth: iron<sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref></sup> and complement factor H (FH)<sup><xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>,<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref></sup>. Since we did not have premorbid blood samples we used convalescent blood, collected 28 days after treatment, as a proxy for pre-infection status (Supplementary Dataset). Iron deficiency is protective against malaria<sup><xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref></sup> and reduces parasite multiplication <italic toggle="yes">in vitro</italic> <sup><xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">29</xref></sup>. Consistent with this, levels of hepcidin (a regulator of iron metabolism and marker of iron sufficiency or deficiency<sup><xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref></sup>) were significantly correlated with <italic toggle="yes">m</italic> (r=0.27, <italic toggle="yes">P</italic>= 0.009) in 92 children who had not received blood transfusion (<xref ref-type="fig" rid="figE3" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Extended Data Figure 3</xref>). FH is a constitutive negative regulator of complement activation which protects host cells from complement mediated lysis<sup><xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref></sup>. Many pathogens including <italic toggle="yes">P. falciparum</italic> have evolved FH binding proteins<sup><xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-2" hwp:rel-id="ref-30">30</xref>,<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-2" hwp:rel-id="ref-31">31</xref></sup>, and FH protects blood-stage parasites from complement mediated killing <italic toggle="yes">in vitro</italic> <sup><xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-3" hwp:rel-id="ref-30">30</xref>,<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-3" hwp:rel-id="ref-31">31</xref>,<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">34</xref></sup>. In 14 children with additional day 28 plasma available (Supplementary Data Set) we found that FH was significantly correlated with <italic toggle="yes">m</italic> (r=0.66, <italic toggle="yes">P</italic> = 0.01) (<xref ref-type="fig" rid="figE3" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Extended Data Figure 3</xref>). Thus, the quantitative estimates of parasite multiplication and PGI from our model exhibit the expected relationships with known constitutive determinants of parasite growth and this provides further evidence to support the validity of the method.</p><p hwp:id="p-17">Using a model-based approach to estimate the within-host dynamics of pathogen load and its determinants in human infection we could estimate the relative contributions of parasite multiplication and host response to pathogen load measured at a single point in time, and we have used these predictions to identify mechanistic correlates of host resistance to malaria. Our approach is based on assumptions which are reasonable, but largely unverifiable, and alternative approaches are possible. However, our biological validation suggests that the relative estimates of <italic toggle="yes">m</italic> and PGI are accurate enough to be useful, providing proof-of –principle that pathogen load dynamics can be estimated in humans. Our approach could be refined and expanded to identify additional biological determinants of pathogen load such as genetic correlates of <italic toggle="yes">m</italic> and <italic toggle="yes">P<sub>c</sub></italic>, or serological correlates of <italic toggle="yes">m</italic> and PGI. This has the potential to yield further novel insights into host-pathogen interactions in malaria, to facilitate discovery of new therapeutic and vaccine strategies, and improve predictive modelling of their impact on disease. Our findings indicate leads for development of host-directed therapeutics to augment antimalarial treatment, particularly in the setting of drug resistant parasites. Inhibition of type-1 interferon or CXCL10 signalling is a realistic option with inhibitory antibodies and small molecules already in development for other indications<sup><xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>,<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref></sup>. The therapeutic potentials of cathepsin G and MMP9 may be counterbalanced by risk of collateral tissue damage, but selective targeting of receptors on the erythrocyte surface may be a useful paradigm for both treatment and prevention of malaria.</p><table-wrap id="tblE1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/TBLE1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tblE1</object-id><label>Extended Data Table 1.</label><caption hwp:id="caption-4"><title hwp:id="title-6">Characteristics of 139 Gambian children with malaria</title></caption><graphic xlink:href="321463_tblE1" position="float" orientation="portrait" hwp:id="graphic-4"/></table-wrap><table-wrap id="tblE2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/TBLE2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tblE2</object-id><label>Extended Data Table 2.</label><caption hwp:id="caption-5"><title hwp:id="title-7">Model parameters and assumptions</title></caption><graphic xlink:href="321463_tblE2" position="float" orientation="portrait" hwp:id="graphic-5"/><graphic xlink:href="321463_tblE2a" position="float" orientation="portrait" hwp:id="graphic-6"/></table-wrap><table-wrap id="tblE3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/TBLE3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tblE3</object-id><label>Extended Data Table 3.</label><caption hwp:id="caption-6"><title hwp:id="title-8">Comparison of general additive models to predict <italic toggle="yes">m</italic> and <italic toggle="yes">P<sub>c</sub></italic></title></caption><graphic xlink:href="321463_tblE3" position="float" orientation="portrait" hwp:id="graphic-7"/></table-wrap><table-wrap id="tblE4" orientation="portrait" position="float" hwp:id="T4" hwp:rev-id="xref-table-wrap-4-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/TBLE4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tblE4</object-id><label>Extended Data Table 4.</label><caption hwp:id="caption-7"><title hwp:id="title-9">Characteristics of subjects used for RNA sequencing</title></caption><graphic xlink:href="321463_tblE4" position="float" orientation="portrait" hwp:id="graphic-8"/></table-wrap><table-wrap id="tblE5" orientation="portrait" position="float" hwp:id="T5" hwp:rev-id="xref-table-wrap-5-1 xref-table-wrap-5-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/TBLE5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T5</object-id><object-id pub-id-type="publisher-id">tblE5</object-id><label>Extended Data Table 5.</label><caption hwp:id="caption-8"><p hwp:id="p-18">Most enriched gene ontology (GO) biological process terms</p></caption><graphic xlink:href="321463_tblE5" position="float" orientation="portrait" hwp:id="graphic-9"/><graphic xlink:href="321463_tblE5a" position="float" orientation="portrait" hwp:id="graphic-10"/></table-wrap><table-wrap id="tblE6" orientation="portrait" position="float" hwp:id="T6" hwp:rev-id="xref-table-wrap-6-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/TBLE6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T6</object-id><object-id pub-id-type="publisher-id">tblE6</object-id><label>Extended Data Table 6.</label><caption hwp:id="caption-9"><p hwp:id="p-19">Antibodies used to assess erythrocyte surface receptor expression</p></caption><graphic xlink:href="321463_tblE6" position="float" orientation="portrait" hwp:id="graphic-11"/></table-wrap></sec><sec id="s2" sec-type="supplementary-material" hwp:id="sec-2"><title hwp:id="title-10">Extended Data Figures</title><fig id="figE1" position="float" orientation="portrait" fig-type="figure" hwp:id="F4" hwp:rev-id="xref-fig-4-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIGE1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">figE1</object-id><label>Extended Data Figure 1.</label><caption hwp:id="caption-10"><title hwp:id="title-11">The dynamics of pathogen load in malariatherapy patients.</title><p hwp:id="p-20">Change in parasite density over time (for the first wave of parasitemia in 97 malariatherapy patients. Each plot represents one subject. Dots indicate observed parasite densities on alternate days; dashed line, observed fever threshold: solid line: fit of modelled trajectory of parasite density.</p></caption><graphic xlink:href="321463_figE1" position="float" orientation="portrait" hwp:id="graphic-12"/></fig><fig id="figE2" position="float" orientation="portrait" fig-type="figure" hwp:id="F5" hwp:rev-id="xref-fig-5-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIGE2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">figE2</object-id><label>Extended Data Fig. 2</label><caption hwp:id="caption-11"><title hwp:id="title-12">Effect of MMP9 treatmenton erythrocyte surface receptors.</title><p hwp:id="p-21">Median fluorescent intensity of erythrocyte surface molecule expression following MMP9 treatment (n=3 biological replicates per condition, mean and range). None were significantly different to the control condition using t-test.</p></caption><graphic xlink:href="321463_figE2" position="float" orientation="portrait" hwp:id="graphic-13"/></fig><fig id="figE3" position="float" orientation="portrait" fig-type="figure" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIGE3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">figE3</object-id><label>Extended Data Fig 3</label><caption hwp:id="caption-12"><title hwp:id="title-13">Correlates of parasite multiplication rate</title><p hwp:id="p-22">(<bold>a, b</bold>) Predicted parasite multiplication rate, <italic toggle="yes">m</italic>, was correlated with hepcidin concentration (<bold>a</bold>, n=92) and complement factor H (FH) concentration (<bold>b</bold> n=14) in convalescent plasma obtained from children 28 days after treatment for malaria. Blue line, linear regression: grey shading. 95% Cl; <italic toggle="yes">P</italic>, Pearson correlation.</p></caption><graphic xlink:href="321463_figE3" position="float" orientation="portrait" hwp:id="graphic-14"/></fig><fig id="figE4" position="float" orientation="portrait" fig-type="figure" hwp:id="F7" hwp:rev-id="xref-fig-7-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIGE4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">figE4</object-id><label>Extended Data Fig. 4</label><caption hwp:id="caption-13"><title hwp:id="title-14">Gating strategies fortlow cytometry analyses</title><p hwp:id="p-23">(<bold>a</bold>) Gating for determination of parasitemia by flow cytometry based on staining of infected red blood cell with dihydroethidium (DHE) and Hoechst. (<italic toggle="yes">b</italic>) Gating on red blood cells for determination of surface molecule expression by fluorescence intensity (example of glycophorin C fluorescence compared with isotype fluorescence).</p></caption><graphic xlink:href="321463_figE4" position="float" orientation="portrait" hwp:id="graphic-15"/></fig></sec><sec id="s3" hwp:id="sec-3"><title hwp:id="title-15">Materials and Methods</title><sec id="s3a" hwp:id="sec-4"><title hwp:id="title-16">Subjects and laboratory assays</title><p hwp:id="p-24">We used data from all of the malariatherapy patients reported by Dietz et al.<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-4" hwp:rel-id="ref-4">4</xref></sup> and from all 139 Gambian subjects reported in our previous studies<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>,<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>,<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref></sup> who had all of the following data available: age, parasite biomass estimate, plasma TNF concentration, duration of illness and severity of illness. No subjects were excluded after this selection, and all available data was included in analyses, without any exclusion of outliers. As described previously<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-2" hwp:rel-id="ref-37">37</xref>,<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-2" hwp:rel-id="ref-40">40</xref>,<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-2" hwp:rel-id="ref-41">41</xref></sup>, Gambian children (&lt;16 years old) were recruited with parental consent from three peri-urban health centres in the Greater Banjul region, from August 2007 through January 2011 as part of a study approved by the Gambia Government/MRC Laboratories Joint Ethics Committee, and the Ethics Committee of the London School of Hygiene and Tropical Medicine. <italic toggle="yes">P. falciparum</italic> malaria was defined by compatible clinical symptoms in the presence of ≥5000 asexual parasites/µL blood, and any children suspected or proven to have bacterial co-infection were excluded. Severe malaria was specifically defined by the presence of prostration (SM1) or any combination of three potentially overlapping syndromes (cerebral malaria (CM), severe anemia (SA, hemoglobin &lt;5 g/dL), and hyperlactatemia (blood lactate &gt;5 mmol/L) – collectively SM2)<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-3" hwp:rel-id="ref-37">37</xref>,<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-3" hwp:rel-id="ref-41">41</xref>,<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref></sup>. Clinical laboratory assays, measurements of plasma TNF and IL-10 by Luminex, measurements of gene expression by RT-PCR, and estimation of total parasite biomass from <italic toggle="yes">Pf</italic> HRP2 ELISA have been previously described<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-4" hwp:rel-id="ref-37">37</xref>,<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-4" hwp:rel-id="ref-41">41</xref></sup>. Subject-level data from these Gambian children is available as <bold>Supplementary Dataset</bold>.</p></sec><sec id="s3b" hwp:id="sec-5"><title hwp:id="title-17">Statistical analyses</title><p hwp:id="p-25">Statistical analyses were undertaken using the R statistical software<sup><xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref></sup> and GraphPad Prism (GraphPad Software, Inc.). Continuous variables were compared between groups using unpaired or paired student’s t-test (when normally distributed) and the Mann-Whitney-Wilcoxon or Wilcoxon matched pairs tests (when normal distribution could not be assumed), or ANOVA for comparison across multiple groups. Correlations were assessed using Pearson’s correlation, after log transformation of the data if appropriate. All hypothesis tests were two-sided with alpha = 0.05, unless specifically indicated otherwise. One-sided testing was only used when consistent with the <italic toggle="yes">a priori</italic> hypothesis. Associations between explanatory variables and latent variables were assessed using generalized additive models (GAM<sup><xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref></sup>, using the R package “mgcv”) and explained variance was used to select the best GAM once all model terms were significant (<italic toggle="yes">P</italic>&lt;0.05). Dose-response curves were fitted using asymmetrical sigmoidal five-parameter logistic equation in GraphPad Prism.</p></sec><sec id="s3c" hwp:id="sec-6"><title hwp:id="title-18">Model relating parasite multiplication, host response and parasite load</title><p hwp:id="p-26">A process-based, stochastic simulation model was devised to reproduce the clinical data collected from the Gambian children. This was achieved by combining the information in the Gambian data with a model describing the first wave of parasitemia in non-immune adults who were deliberately infected with <italic toggle="yes">P. falciparum</italic> malaria to treat neurosyphilis (“malariatherapy”)<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-5" hwp:rel-id="ref-4">4</xref></sup>. These malariatherapy data, from the pre-antibiotic era, are the main source of information on the within-host dynamics and between-host variation in the course of parasitemia in untreated malaria infections. The model of Dietz et al.<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-6" hwp:rel-id="ref-4">4</xref></sup> was modified and extended in order to be applied to the Gambian data.</p><p hwp:id="p-27"><italic toggle="yes">Model of ascending parasitemia in malariatherapy subjects</italic>. The model relates parasite density after each 2-day asexual blood stage cycle (P<sub>(t+2)</sub>) to the parasite density at the end of the previous cycle (P<sub>(t)</sub>) by the following equation:
<disp-formula hwp:id="disp-formula-1">
<alternatives hwp:id="alternatives-1"><graphic xlink:href="321463_ueqn1.gif" position="float" orientation="portrait" hwp:id="graphic-16"/></alternatives>
</disp-formula></p><p hwp:id="p-28">The host-specific parasite multiplication rate, <italic toggle="yes">m</italic>, is a property of both parasite and host, allowing for growth-inhibition by constitutive factors; the proportion of parasites that will survive the effects of the density-dependent host response in the present cycle is S<sub>c</sub>:
<disp-formula hwp:id="disp-formula-2">
<alternatives hwp:id="alternatives-2"><graphic xlink:href="321463_ueqn2.gif" position="float" orientation="portrait" hwp:id="graphic-17"/></alternatives>
</disp-formula>, where <italic toggle="yes">P<sub>c</sub></italic> is the host-specific parasite load threshold at which the host response is strong enough to inhibit 50% of parasite growth in that cycle. Consistent with the original Dietz model, P<sub>(0)</sub> was set to 0.003 parasites/µl<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-7" hwp:rel-id="ref-4">4</xref></sup>.</p><p hwp:id="p-29">The original Dietz model included an additional parameter, S<sub><italic toggle="yes">m</italic></sub>, to help describe the decline in parasitemia after the peak of the first wave. S<sub><italic toggle="yes">m</italic></sub> is the proportion of isogenic parasites surviving an additional density- and time-dependent host response, which might represent adaptive immunity<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-8" hwp:rel-id="ref-4">4</xref></sup>. Estimates of the range of values of S<sub><italic toggle="yes">m</italic></sub> in the Dietz dataset and model were used when simulating data but since this parameter has little influence on parasite densities prior to the peak it was not used to make subsequent predictions of <italic toggle="yes">m</italic> and <italic toggle="yes">P<sub>c</sub></italic> in individual Gambian subjects.</p><p hwp:id="p-30">At the explicit request of Klaus Dietz and Louis Molineaux, we hereby communicate the following correction regarding their assertion that the malariatherapy patients had not received any treatment<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-9" hwp:rel-id="ref-4">4</xref></sup>: it was later found that 47 of these patients had indeed received subcurative treatment, and that those patients had significantly higher parasite densities. This is unlikely to influence our analysis, because treatment would only be provided when malariatherapy patients became very unwell, presumably at maximum parasitemia, whereas most patients with naturally acquired infection likely present prior to the peak parasitemia that might occur in the absence of treatment.</p><p hwp:id="p-31"><italic toggle="yes">Fitting of the malariatherapy model to data from Gambian children.</italic> Individual-level parameter estimates for the malaria therapy dataset were kindly provided by Klaus Dietz. The logarithms of these 97 estimates of <italic toggle="yes">m</italic> and <italic toggle="yes">P</italic><sub>c</sub> were well described by a multivariate normal distribution, providing a quantitative description of inter-individual variation in the dynamics of the first wave of parasitemia. In order to use the Dietz model to simulate the Gambian data, a number of modifications and extensions were made. Some of these required estimation of additional parameters by comparing the model simulations with the Gambian data. Dietz et al. provided a statistical description of the parasite density at which first fever occurred (the “fever threshold”) in the form of the distribution of the ratio of threshold density to peak parasitemia. The median density at first fever was at 1.4% of peak density. We introduced the assumption that the onset of fever occurs at a particular threshold value of <italic toggle="yes">S<sub>c</sub></italic>, because fever is dependent on the production of cytokines like interleukin-6 and TNF, both components of the host response. This constitutes a process-based model for the onset of fever rather than a purely statistical one. Because individuals differ in their response to parasite load (captured through variation in <italic toggle="yes">P<sub>c</sub></italic>), this results in variation of parasite densities at first fever but ignores any potential variation among individuals with respect to host response at onset of fever. The host response threshold for the onset of fever <inline-formula hwp:id="inline-formula-1"><alternatives hwp:id="alternatives-3"><inline-graphic xlink:href="321463_inline1.gif" hwp:id="inline-graphic-1"/></alternatives></inline-formula> = 0.86 was determined as the value of <italic toggle="yes">S<sub>c</sub></italic> calculated at 1.4% of the peak density of a simulated individual with the median parameter values. This yielded a distribution of fever ratios similar to the one described by Dietz et al.<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-10" hwp:rel-id="ref-4">4</xref></sup>, albeit with less variation.</p><p hwp:id="p-32">To simulate the time between onset of fever and clinical presentation we made use of the self-reported duration of symptoms in the Gambian data. The model which was most consistent with these values assumed a gamma-distributed duration of symptoms in non-severe cases, and a possibility to present earlier in the case of more severe disease. Since parasite biomass is related to likelihood of having severe malaria<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-5" hwp:rel-id="ref-37">37</xref>,<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref></sup> the probability of early presentation on any day after onset of fever was set proportional to the (density-dependent) probability of having severe disease on that day. Scale (ζ) and shape (κ) parameters of the gamma distribution as well as the factor (ξ) for determining the probability of early presentation were estimated from the Gambian data.</p><p hwp:id="p-33">We assumed that TNF production τ(t) increases monotonically with density dependent host response (1-<italic toggle="yes">S<sub>c</sub></italic>) and represented this relationship using a heuristic function of the form</p><disp-formula hwp:id="disp-formula-3">
<alternatives hwp:id="alternatives-4"><graphic xlink:href="321463_ueqn3.gif" position="float" orientation="portrait" hwp:id="graphic-18"/></alternatives>
</disp-formula><p hwp:id="p-34">, with free parameters a, b, λ<sup>*</sup> and γ estimated from the Gambian data.</p><p hwp:id="p-35">The Gambian children had on average higher parasite densities than the malariatherapy patients, which led to a bad fit of the original model to the Gambian data. This was overcome by introducing the assumption that the Gambian children had a different range of values of <italic toggle="yes">P<sub>c</sub></italic> to the adult malariatherapy patients. A factor π was therefore estimated by which the ln <italic toggle="yes">P<sub>c</sub></italic> value from the Dietz model was multiplied. This led to overall higher parasite densities upon presentation. However, our model uses parasite biomass and its relationship with disease severity to predict day of presentation, and there is an interaction between the mean ln <italic toggle="yes">P<sub>c</sub></italic> and the variation in ln <italic toggle="yes">P<sub>c</sub></italic>, as well as the proportion of severe malaria in the simulated Gambian population. Based on the relatively low malaria transmission in the Banjul area of The Gambia, we assumed that severe cases (defined by the presence of any of: prostration, hyperlactatemia, severe anemia or cerebral malaria) were over-represented by hospital-based recruitment and that in an unselected population of children of similar age to those in our dataset only approximately 5% of all malaria infections would be severe<sup><xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref></sup>. Therefore we estimated a factor δ by which the variance of ln <italic toggle="yes">P<sub>c</sub></italic> should be multiplied such that both rate of severity as well as the distribution of parasite biomass matched well after fitting our simulation to the Gambian data.</p><p hwp:id="p-36">The free parameters ζ, κ, ξ, a, b, λ<sup>*</sup>, γ, π and δ, together summarized as θ, were estimated by fitting model simulations to the information on TNF, parasite density, and duration of symptoms, for any given candidate parameterization, a total of 139 clinically presenting individuals were simulated from the model, which corresponds to the size of the Gambian dataset. An objective function L(θ) was calculated, and a simulated annealing algorithm (provided by the “optim” function in R) determined the value for θ which maximizes this function. The log-likelihood L (θ) was comprised of three separate objectives. The first objective represented the log-probability that the frequency of severe cases in the simulation was equal to an assumed 5%, employing a binomial likelihood, given the actual number of severe cases sampled in 139 simulated individuals. The second objective considered the overlap between the bivariate distribution of ln parasite density vs. ln TNF concentration in the simulated data compared to the Gambian dataset. An approximate numerical value for this partial log-likelihood was obtained as the log probability of the Gambian data (density and TNF) given a two-dimensional kernel density estimate of the simulation output as a likelihood model. Kernel density estimates were obtained using the “kde2d” function in the “MASS” package in R. In this calculation, the TNF/density data points of severe or prostrated Gambian patients entered the partial likelihood with a weight of 1/11, to account for the oversampling of severe cases in the Gambian data. The third objective concerned the two- dimensional distribution of log density and duration since first fever. This partial log-likelihood was obtained using the same kernel-based approach described above, with weights of 1/11 for severe and prostrated cases. The overall log-likelihood L (θ) was calculated as a weighted sum of the three partial log-likelihoods, with the log-probability of having the desired true severity rate weighted with a factor of 68, which ensured similar magnitude of the three partial log-likelihoods at the optimum.</p><p hwp:id="p-37">The results of the fitting algorithm were visually confirmed to yield a good overlap of the joint distributions of density and biomass, the duration of symptoms, TNF and biomass between simulation and the Gambian children. Approximate confidence intervals for the parameter estimates were determined by employing a 2<sup>nd</sup> degree polynomial to estimate the curvature of the maximum simulated likelihood surface in the vicinity of the parameter point estimate, assuming independence of parameters.</p><p hwp:id="p-38">As in the original model of Dietz et al.<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-11" hwp:rel-id="ref-4">4</xref></sup>, peripheral parasite densities were used to determine the dynamic changes in parasitemia, implying a correlation between peripheral densities and total parasite biomass. For the purpose of determining disease severity, total parasite biomass per kg was calculated from the predicted parasite density by the equation 70,000 × 1.09 × predicted parasite density in parasites/µL, as has been determined previously for uncomplicated malaria cases in the Gambian dataset<sup><xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-6" hwp:rel-id="ref-37">37</xref></sup>. The source code for the model and examples of its use are presented as <bold>Supplementary Code File</bold>.</p><p hwp:id="p-39"><italic toggle="yes">Deterministic relationships between real and latent variables.</italic> The range of values of <italic toggle="yes">m</italic> and ln <italic toggle="yes">P<sub>c</sub></italic> in a simulated population of 2000 patients were determined and each divided into 50 equally spaced increments in order to generate 2500 possible combinations of <italic toggle="yes">m</italic> and ln <italic toggle="yes">P<sub>c</sub></italic> for which all model outcomes were determined. For the purpose of this analysis, the time-dependent adaptive immune response parameters (which comprise <italic toggle="yes">S<sub>m</sub></italic>) were set for all subjects at their respective population median values. The model of Dietz <italic toggle="yes">et al</italic>. makes use of discrete 2 day time intervals<sup><xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-12" hwp:rel-id="ref-4">4</xref></sup>, corresponding to the duration of the intraerythrocytic cycle in a highly synchronized infection. However, naturally acquired infections are rarely this synchronous<sup><xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-2" hwp:rel-id="ref-38">38</xref></sup> and the time since infection of our Gambian patients is an unknown continuous variable. In order to cope with this we assumed that the relationship between predicted outcome variables (parasite biomass, duration of illness and TNF concentration) and explanatory variables (<italic toggle="yes">m</italic> and <italic toggle="yes">P<sub>c</sub></italic>) could be approximated by smoothed GAM<sup><xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-2" hwp:rel-id="ref-44">44</xref></sup>. We used the GAM to estimate values of <italic toggle="yes">m, P<sub>c</sub></italic> and parasite growth inhibition (PGI, 1-<italic toggle="yes">S<sub>c</sub></italic>) in the Gambian children, based on their known total parasite biomass, duration of symptoms and TNF concentration.</p></sec><sec id="s3d" hwp:id="sec-7"><title hwp:id="title-19">RNA-sequencing and data analysis</title><p hwp:id="p-40">Total RNA was extracted using the PAXgene Blood RNA kit (BD) and quality assessed using the Agilent 6000 RNA Nano kit and Bioanalyzer. Library preparation and sequencing were performed by Exeter University sequencing service. Libraries were prepared from 1μg of total RNA using the ScriptSeq v2 RNA-seq library preparation kit (Illumina) with additional steps to remove ribosmal RNA (rRNA) and globin messenger RNA (mRNA) using Globin-Zero Gold kit (Epicentre). Strand-specific libraries were sequenced using the 2×100 bp protocol with an Illumina HiSeq 2500. Samples were randomized for order of library preparation and then randomly allocated to sequencing lanes in a block design to ensure a balance of SM and UM samples (5–6 samples per lane) to eliminate batch effects. The reference genomes hg38 (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://genome.ucsc.edu/" ext-link-type="uri" xlink:href="http://genome.ucsc.edu/" hwp:id="ext-link-1">http://genome.ucsc.edu/</ext-link>) and <italic toggle="yes">P. falciparum</italic> reference genome release 24 (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://plasmodb.org/" ext-link-type="uri" xlink:href="http://plasmodb.org/" hwp:id="ext-link-2">http://plasmodb.org/</ext-link>) were used for human and parasite respectively. Human gene annotation was obtained from GENCODE (release 22) (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://gencodegenes.org/releases/" ext-link-type="uri" xlink:href="http://gencodegenes.org/releases/" hwp:id="ext-link-3">http://gencodegenes.org/releases/</ext-link>) and <italic toggle="yes">P. falciparum</italic> gene annotation from PlasmoDB (release 24) (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://plasmodb.org" ext-link-type="uri" xlink:href="http://plasmodb.org" hwp:id="ext-link-4">http://plasmodb.org</ext-link>). RNA-seq data was mapped to the combined genomic index containing both human and <italic toggle="yes">P. falciparum</italic> genomes using splice-aware STAR aligner, allowing up to 8 mismatches for each paired-end read<sup><xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref></sup>. Reads were then extracted from the output BAM file to separate parasite-mapped reads from human-mapped reads. Reads mapping to both genomes were counted for each sample and removed. BAM files were also sorted, read groups replaced with a single new read group and all reads assigned to it, and indexed to run RNASeQC, a tool for computing quality control metrics for RNA-seq data<sup><xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref></sup>. Only exclusively human-mapped reads were used for further analysis. HTSeq-count was used to count the reads mapped to exons with the parameter “-m union”<sup><xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref></sup>. With the R package edgeR, raw read counts were normalized using a trimmed mean of M-values (TMM), which takes into account the library size and the RNA composition of the input data<sup><xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref></sup>. To account for inter-individual variation in the proportions of different types of blood leukocyte, deconvolution analysis was performed using CellCODE<sup><xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref></sup>. Leukocyte expression signatures were taken from the in-built Immune Response In Silico (IRIS<sup><xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref></sup>) dataset for: neutrophil, monocyte, CD4+ T-cell, CD8+ T-cell, and B-cell. Fragments Per Kilobase of transcript per Million mapped reads (FPKM) values were calculated from human RNA-seq data and log-transformed to simulate a microarray data set. Surrogate proportion variables for each sample were calculated for each of the cell types.</p><p hwp:id="p-41">The association of gene expression with <italic toggle="yes">m</italic> and PGI was determined using a generalized linear model approach in edgeR, allowing adjustment for leukocyte SPVs. False discovery rate (FDR) was computed using the Benjamini-Hochberg approach and FDR below 0.05 was considered to be significant. Gene ontology (GO) terms were obtained from Bioconductor package “org.Hs.eg.db”. Fisher’s exact test was used to identify significantly over-represented GO terms from gene lists. The background gene sets consisted of all expressed genes detected in the data set. Enrichment analysis for biological process terms was carried out using the “goana()” function in edgeR. REVIGO was used to identify the most significant non-redundant GO terms<sup><xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">51</xref></sup>. Using groups of genes significantly positively or negatively correlated with PGI, Ingenuity Pathway Analysis (Qiagen) was used to identify networks of genes functionally linked by regulators, interactions or downstream effects, which were visualized as radial plots centered around the most connected network member.</p></sec><sec id="s3e" hwp:id="sec-8"><title hwp:id="title-20">Parasite culture, growth and invasion assays</title><p hwp:id="p-42"><italic toggle="yes">P. falciparum</italic> 3D7 strain was used in continuous culture for all of the experiments unless otherwise stated. Asexual blood stage parasites were cultured in human blood group A red cells, obtained from the National Blood Service, at 1–5% hematocrit, 37 °C, 5% CO<sub>2</sub> and low oxygen (1% or 5%) as described previously<sup><xref ref-type="bibr" rid="c52" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">52</xref>,<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">53</xref></sup>. Growth medium was RPMI-1640 (without L-glutamine, with HEPES) (Sigma) supplemented with 5 g/L Albumax II (Invitrogen), 147 µM hypoxanthine, 2 mM L-glutamine, and 10 mM D-glucose. Parasite developmental stage synchronization was performed using 5% D-sorbitol to obtain ring stage parasites or Percoll gradients for schizont stage enrichment<sup><xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-2" hwp:rel-id="ref-53">53</xref>,<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">54</xref></sup>. For growth assays, schizonts were mixed at &lt;1% parasitemia with uninfected erythrocytes at 2% final hematocrit. Cathepsin G (Abcam) or recombinant active MMP9 [Enzo] were added for 72 hour incubation to allow two replication cycles. Growth under each condition was calculated relative to the average growth in untreated samples. Invasion assays were performed by adding parasites synchronised at the schizont stage to target erythrocytes and incubating for 24 hours. Cathepsin G and MMP9 were either pre-incubated with the target cells overnight followed by four washes with RPMI to completely remove them, or they were added directly to the culture of schizonts with target erythrocytes for 24 hours. The same protocol was followed for other <italic toggle="yes">P. falciparum</italic> strains except Dd2, for which magnetic purification was used to purify schizonts<sup><xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">55</xref></sup>.</p></sec><sec id="s3f" hwp:id="sec-9"><title hwp:id="title-21">Flow cytometry for parasitemia and erythrocyte surface receptor expression</title><p hwp:id="p-43">Flow cytometry was performed using a BD LSR Fortessa machine and analysis was conducted using FlowJo v10 (TreeStar Inc.), and gating strategies are show in <xref ref-type="fig" rid="figE4" hwp:id="xref-fig-7-1" hwp:rel-id="F7">Extended Data Figure 4.</xref> To assess parasitemia, 1µl of sample at 50% hematocrit was stained with Hoechst 33342 (Sigma) and dihydroethidium (Sigma) and then fixed with 2% paraformaldehyde (PFA) before flow cytometry as previously described<sup><xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">56</xref></sup>. Erythrocyte surface receptor expression was assessed by median fluorescence intensity of erythrocytes labelled with monoclonal antibodies or by comparison with isotype control antibodies (<xref ref-type="table" rid="tblE6" hwp:id="xref-table-wrap-6-1" hwp:rel-id="T6">Extended Data Table 6</xref>). Briefly, erythrocytes were washed twice before resuspending at 50% haematocrit, of which 1–2µl was stained in 100µl of antibody cocktail in FACS buffer (2% fetal bovine serum, 0.01% sodium azide in PBS) for 30 minutes in the dark on ice. Samples were washed twice in FACS buffer and then fixed in 300µl FACS buffer with 2% paraformaldehyde. Surface receptor loss was calculated from the difference between the treated and untreated sample median fluorescent intensities after the isotype control antibody fluorescence had been subtracted.</p></sec><sec id="s3g" hwp:id="sec-10"><title hwp:id="title-22">Whole blood stimulation and Cathepsin G and MMP9 ELISA</title><p hwp:id="p-44">Whole blood was collected from 8 healthy adult donors and plated at 25% hematocrit, and incubated overnight with or without 1µM PMA (Sigma). Supernatant was collected to perform Cathepsin G (CTSG ELISA Kit-Human, Aviva Systems Biology) and MMP9 (Legend Max Human MMP-9, Biolegend) ELISAs, and erythrocytes were collected for surface staining. The same ELISA kits were used to measure cathepsin G and MMP9 in acute (day 0) plasma samples from children with malaria.</p></sec><sec id="s3h" hwp:id="sec-11"><title hwp:id="title-23">Hepcidin and Complement Factor H ELISA</title><p hwp:id="p-45">The hepcidin concentration was measured 28 days after infection in plasma from subjects who had not received blood transfusion using the Hepcidin-25 bioactive ELISA kit (DRG) according to the manufacturer’s instructions, with duplicate measurements when sufficient plasma was available. Complement Factor H assays were performed using an in-house ELISA as described<sup><xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">57</xref></sup>.</p></sec><sec id="s3i" hwp:id="sec-12"><title hwp:id="title-24">Data availability</title><p hwp:id="p-46">Estimates of parameters determining within-host dynamics in malariatherapy dataset were obtained from reference 4, whose corresponding author may be contacted at <email hwp:id="email-2">klaus.dietz@unituebingen.de</email>. Data from the Gambian subjects are presented as Supplementary Dataset. RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.ebi.ac.uk/arrayexpress" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress" hwp:id="ext-link-5">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-6413.</p></sec><sec id="s3j" hwp:id="sec-13"><title hwp:id="title-25">Code availability</title><p hwp:id="p-47">The source code for the mathematical model, and examples of its use, are presented as Supplementary material.</p></sec></sec><sec id="s4" sec-type="supplementary-material" hwp:id="sec-14"><title hwp:id="title-26">Supplementary Materials</title><fig id="figS1" position="float" orientation="portrait" fig-type="figure" hwp:id="F8" hwp:rev-id="xref-fig-8-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;321463v1/FIGS1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">figS1</object-id><label>Supplementary Fig 1.</label><caption hwp:id="caption-14"><title hwp:id="title-27">Fit of TNF concentration to parasite growth inhibition.</title><p hwp:id="p-48">Parameter estimation during model fitting suggested that TNF would increase above the limit of detection at a relatively late stage in the host response, when it would augment parasite killing (approximate 95% confidence interval in red)</p></caption><graphic xlink:href="321463_figS1" position="float" orientation="portrait" hwp:id="graphic-19"/></fig><p hwp:id="p-49"><bold>Supplementary Dataset. Data from the Gambian children with malaria.</bold></p><p hwp:id="p-50"><bold>Supplementary Code Zip File. Containing README file, R library file for the mathematical model, R Example file for the mathematical model.</bold></p></sec></body><back><ref-list hwp:id="ref-list-1"><title hwp:id="title-28">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Plotkin S. A."><surname>Plotkin</surname>, <given-names>S. A.</given-names></string-name> <article-title hwp:id="article-title-2">Complex correlates of protection after vaccination</article-title>. <source hwp:id="source-1">Clin Infect Dis</source> <volume>56</volume>, <fpage>1458</fpage>–<lpage>1465</lpage> (<year>2013</year>).</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Zumla A."><surname>Zumla</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-3">Host-directed therapies for infectious diseases: current status, recent progress, and future prospects</article-title>. <source hwp:id="source-2">Lancet Infect Dis</source> <volume>16</volume>, <fpage>e47</fpage>–<lpage>63</lpage> (<year>2016</year>).</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>3</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Cunnington A. J."><surname>Cunnington</surname>, <given-names>A. J.</given-names></string-name> <article-title hwp:id="article-title-4">The importance of pathogen load</article-title>. <source hwp:id="source-3">PLoS Pathog</source> <volume>11</volume>, <fpage>e1004563</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1004563</pub-id> (<year>2015</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1 xref-ref-4-2 xref-ref-4-3 xref-ref-4-4 xref-ref-4-5 xref-ref-4-6 xref-ref-4-7 xref-ref-4-8 xref-ref-4-9 xref-ref-4-10 xref-ref-4-11 xref-ref-4-12"><label>4</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Dietz K."><surname>Dietz</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raddatz G."><surname>Raddatz</surname>, <given-names>G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Molineaux L."><surname>Molineaux</surname>, <given-names>L.</given-names></string-name> <article-title hwp:id="article-title-5">Mathematical model of the first wave of Plasmodium falciparum asexual parasitemia in non-immune and vaccinated individuals</article-title>. <source hwp:id="source-4">Am J Trop Med Hyg</source> <volume>75</volume>, <fpage>46</fpage>–<lpage>55</lpage> (<year>2006</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Kumaratilake L. M."><surname>Kumaratilake</surname>, <given-names>L. M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferrante A."><surname>Ferrante</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Rzepczyk C. M."><surname>Rzepczyk</surname>, <given-names>C. M.</given-names></string-name> <article-title hwp:id="article-title-6">Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum</article-title>. <source hwp:id="source-5">Infect Immun</source> <volume>58</volume>, <fpage>788</fpage>–<lpage>793</lpage> (<year>1990</year>).</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>6</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Kumaratilake L. M."><surname>Kumaratilake</surname>, <given-names>L. M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-7">A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice</article-title>. <source hwp:id="source-6">J Clin Invest</source> <volume>95</volume>, <fpage>2315</fpage>–<lpage>2323</lpage>, doi:<pub-id pub-id-type="doi">10.1172/JCI117923</pub-id> (<year>1995</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Smith T."><surname>Smith</surname>, <given-names>T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-8">Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area</article-title>. <source hwp:id="source-7">Parasitology</source> <volume>109</volume> (<issue>Pt 5</issue>), <fpage>539</fpage>–<lpage>549</lpage> (<year>1994</year>).</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>8</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="White N. J."><surname>White</surname>, <given-names>N. J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-9">Malaria</article-title>. <source hwp:id="source-8">Lancet</source> <volume>383</volume>, <fpage>723</fpage>–<lpage>735</lpage> (<year>2014</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>9</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Crompton P. D."><surname>Crompton</surname>, <given-names>P. D.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-10">Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease</article-title>. <source hwp:id="source-9">Annu Rev Immunol</source> <volume>32</volume>, <fpage>157</fpage>–<lpage>187</lpage> (<year>2014</year>).</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Ceesay S. J."><surname>Ceesay</surname>, <given-names>S. J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-11">Continued decline of malaria in The Gambia with implications for elimination</article-title>. <source hwp:id="source-10">PLoS One</source> <volume>5</volume>, <fpage>e12242</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0012242</pub-id> (<year>2010</year>).</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><label>11</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Okebe J."><surname>Okebe</surname>, <given-names>J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-12">School-based countrywide seroprevalence survey reveals spatial heterogeneity in malaria transmission in the Gambia</article-title>. <source hwp:id="source-11">PLoS One</source> <volume>9</volume>, <fpage>e110926</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0110926</pub-id> (<year>2014</year>).</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><label>12</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Arthur J. S."><surname>Arthur</surname>, <given-names>J. S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Ley S. C."><surname>Ley</surname>, <given-names>S. C.</given-names></string-name> <article-title hwp:id="article-title-13">Mitogen-activated protein kinases in innate immunity</article-title>. <source hwp:id="source-12">Nat Rev Immunol</source> <volume>13</volume>, <fpage>679</fpage>–<lpage>692</lpage>, doi:<pub-id pub-id-type="doi">10.1038/nri3495</pub-id> (<year>2013</year>).</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>13</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Manning B. D."><surname>Manning</surname>, <given-names>B. D.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Toker A."><surname>Toker</surname>, <given-names>A.</given-names></string-name> <article-title hwp:id="article-title-14">AKT/PKB Signaling: Navigating the Network</article-title>. <source hwp:id="source-13">Cell</source> <volume>169</volume>, <fpage>381</fpage>–<lpage>405</lpage> (<year>2017</year>).</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1 xref-ref-14-2"><label>14</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Spaulding E."><surname>Spaulding</surname>, <given-names>E.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-15">STING-Licensed Macrophages Prime Type I IFN Production by Plasmacytoid Dendritic Cells in the Bone Marrow during Severe Plasmodium yoelii Malaria</article-title>. <source hwp:id="source-14">PLoS Pathog</source> <volume>12</volume>, <fpage>e1005975</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005975</pub-id> (<year>2016</year>).</citation></ref><ref id="c15" hwp:id="ref-15"><label>15</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Zander R. A."><surname>Zander</surname>, <given-names>R. A.</given-names></string-name> <etal>et al.</etal> <string-name name-style="western" hwp:sortable="Type I"><surname>Type</surname> <given-names>I</given-names></string-name> <article-title hwp:id="article-title-16">Interferons Induce T Regulatory 1 Responses and Restrict Humoral Immunity during Experimental Malaria</article-title>. <source hwp:id="source-15">PLoS Pathog</source> <volume>12</volume>, <fpage>e1005945</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005945</pub-id> (<year>2016</year>).</citation></ref><ref id="c16" hwp:id="ref-16"><label>16</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Haque A."><surname>Haque</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-17">Type I IFN signaling in CD8-DCs impairs Th1-dependent malaria immunity</article-title>. <source hwp:id="source-16">J Clin Invest</source> <volume>124</volume>, <fpage>2483</fpage>–<lpage>2496</lpage> (<year>2014</year>).</citation></ref><ref id="c17" hwp:id="ref-17"><label>17</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Haque A."><surname>Haque</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-18">Type I interferons suppress CD4(+) T-cell-dependent parasite control during blood-stage Plasmodium infection</article-title>. <source hwp:id="source-17">Eur J Immunol</source> <volume>41</volume>, <fpage>2688</fpage>–<lpage>2698</lpage> (<year>2011</year>).</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Edwards C. L."><surname>Edwards</surname>, <given-names>C. L.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-19">Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection</article-title>. <source hwp:id="source-18">Eur J Immunol</source> <volume>45</volume>, <fpage>130</fpage>–<lpage>141</lpage> (<year>2015</year>).</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Montes de Oca M."><surname>Montes de Oca</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-20">Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection</article-title>. <source hwp:id="source-19">Cell reports</source> <volume>17</volume>, <fpage>399</fpage>–<lpage>412</lpage> (<year>2016</year>).</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>20</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Ioannidis L. J."><surname>Ioannidis</surname>, <given-names>L. J.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-21">Monocyte-and Neutrophil-Derived CXCL10 Impairs Efficient Control of Blood-Stage Malaria Infection and Promotes Severe Disease</article-title>. <source hwp:id="source-20">J Immunol</source> <volume>196</volume>, <fpage>1227</fpage>–<lpage>1238</lpage> (<year>2016</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>21</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Cowland J. B."><surname>Cowland</surname>, <given-names>J. B.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Borregaard N."><surname>Borregaard</surname>, <given-names>N.</given-names></string-name> <article-title hwp:id="article-title-22">Granulopoiesis and granules of human neutrophils</article-title>. <source hwp:id="source-21">Immunol Rev</source> <volume>273</volume>, <fpage>11</fpage>–<lpage>28</lpage>, doi:<pub-id pub-id-type="doi">10.1111/imr.12440</pub-id> (<year>2016</year>).</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Weksler B. B."><surname>Weksler</surname>, <given-names>B. B.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jaffe E. A."><surname>Jaffe</surname>, <given-names>E. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brower M. S."><surname>Brower</surname>, <given-names>M. S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Cole O. F."><surname>Cole</surname>, <given-names>O. F.</given-names></string-name> <article-title hwp:id="article-title-23">Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells</article-title>. <source hwp:id="source-22">Blood</source> <volume>74</volume>, <fpage>1627</fpage>–<lpage>1634</lpage> (<year>1989</year>).</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>23</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Binks R. H."><surname>Binks</surname>, <given-names>R. H.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Conway D. J."><surname>Conway</surname>, <given-names>D. J.</given-names></string-name> <article-title hwp:id="article-title-24">The major allelic dimorphisms in four Plasmodium falciparum merozoite proteins are not associated with alternative pathways of erythrocyte invasion</article-title>. <source hwp:id="source-23">Mol Biochem Parasitol</source> <volume>103</volume>, <fpage>123</fpage>–<lpage>127</lpage> (<year>1999</year>).</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><label>24</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Satchwell T. J."><surname>Satchwell</surname>, <given-names>T. J.</given-names></string-name> <article-title hwp:id="article-title-25">Erythrocyte invasion receptors for Plasmodium falciparum: new and old</article-title>. <source hwp:id="source-24">Transfusion medicine</source> <volume>26</volume>, <fpage>77</fpage>–<lpage>88</lpage> (<year>2016</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Malaria Genomic Epidemiology N."><surname>Malaria Genomic Epidemiology</surname>, <given-names>N.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Band G."><surname>Band</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rockett K. A."><surname>Rockett</surname>, <given-names>K. A.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Spencer C. C."><surname>Spencer</surname>, <given-names>C. C.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Kwiatkowski D. P."><surname>Kwiatkowski</surname>, <given-names>D. P.</given-names></string-name> <article-title hwp:id="article-title-26">A novel locus of resistance to severe malaria in a region of ancient balancing selection</article-title>. <source hwp:id="source-25">Nature</source> <volume>526</volume>, <fpage>253</fpage>–<lpage>257</lpage> (<year>2015</year>).</citation></ref><ref id="c26" hwp:id="ref-26"><label>26</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Leffler E. M."><surname>Leffler</surname>, <given-names>E. M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-27">Resistance to malaria through structural variation of red blood cell invasion receptors</article-title>. <source hwp:id="source-26">Science</source>, <fpage>eaam6393</fpage>, doi:<pub-id pub-id-type="doi">10.1126/science.aam6393</pub-id> (<year>2017</year>).</citation></ref><ref id="c27" hwp:id="ref-27"><label>27</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Crosnier C."><surname>Crosnier</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-28">Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum</article-title>. <source hwp:id="source-27">Nature</source> <volume>480</volume>, <fpage>534</fpage>–<lpage>537</lpage> (<year>2011</year>).</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><label>28</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Pasvol G."><surname>Pasvol</surname>, <given-names>G.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wainscoat J. S."><surname>Wainscoat</surname>, <given-names>J. S.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Weatherall D. J."><surname>Weatherall</surname>, <given-names>D. J.</given-names></string-name> <article-title hwp:id="article-title-29">Erythrocytes deficiency in glycophorin resist invasion by the malarial parasite Plasmodium falciparum</article-title>. <source hwp:id="source-28">Nature</source> <volume>297</volume>, <fpage>64</fpage>–<lpage>66</lpage> (<year>1982</year>).</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><label>29</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Clark M. A."><surname>Clark</surname>, <given-names>M. A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-30">Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum</article-title>. <source hwp:id="source-29">Nature communications</source> <volume>5</volume>, <fpage>4446</fpage>, doi:<pub-id pub-id-type="doi">10.1038/ncomms5446</pub-id> (<year>2014</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1 xref-ref-30-2 xref-ref-30-3"><label>30</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Kennedy A. T."><surname>Kennedy</surname>, <given-names>A. T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-31">Recruitment of Factor H as a Novel Complement Evasion Strategy for Blood-Stage Plasmodium falciparum Infection</article-title>. <source hwp:id="source-30">J Immunol</source> <volume>196</volume>, <fpage>1239</fpage>–<lpage>1248</lpage> (<year>2016</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1 xref-ref-31-2 xref-ref-31-3"><label>31</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Rosa T. F."><surname>Rosa</surname>, <given-names>T. F.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-32">The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement</article-title>. <source hwp:id="source-31">Cell Microbiol</source> <volume>18</volume>, <fpage>573</fpage>–<lpage>590</lpage> (<year>2016</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Gwamaka M."><surname>Gwamaka</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-33">Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children</article-title>. <source hwp:id="source-32">Clin Infect Dis</source> <volume>54</volume>, <fpage>1137</fpage>–<lpage>1144</lpage> (<year>2012</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Pasricha S. R."><surname>Pasricha</surname>, <given-names>S. R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-34">Expression of the iron hormone hepcidin distinguishes different types of anemia in African children</article-title>. <source hwp:id="source-33">Sci Transl Med</source> <volume>6</volume>, <fpage>235re233</fpage>, doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3008249</pub-id> (<year>2014</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2"><label>34</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Parente R."><surname>Parente</surname>, <given-names>R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clark S. J."><surname>Clark</surname>, <given-names>S. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Inforzato A."><surname>Inforzato</surname>, <given-names>A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Day A. J."><surname>Day</surname>, <given-names>A. J.</given-names></string-name> <article-title hwp:id="article-title-35">Complement factor H in host defense and immune evasion</article-title>. <source hwp:id="source-34">Cell Molecular Life Sci</source> <volume>74</volume>, <fpage>1605</fpage>–<lpage>1624</lpage> (<year>2017</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Oon S."><surname>Oon</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wilson N. J."><surname>Wilson</surname>, <given-names>N. J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wicks I."><surname>Wicks</surname>, <given-names>I.</given-names></string-name> <article-title hwp:id="article-title-36">Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway</article-title>. <source hwp:id="source-35">Clin Transl Immunol</source> <volume>5</volume>, <fpage>e79</fpage>, doi:<pub-id pub-id-type="doi">10.1038/cti.2016.26</pub-id> (<year>2016</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>36</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Pease J. E."><surname>Pease</surname>, <given-names>J. E.</given-names></string-name> <article-title hwp:id="article-title-37">Designing small molecule CXCR3 antagonists</article-title>. <source hwp:id="source-36">Expert Opin Drug Discov</source> <volume>12</volume>, <fpage>159</fpage>–<lpage>168</lpage> (<year>2017</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1 xref-ref-37-2 xref-ref-37-3 xref-ref-37-4 xref-ref-37-5 xref-ref-37-6"><label>37</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Cunnington A. J."><surname>Cunnington</surname>, <given-names>A. J.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bretscher M. T."><surname>Bretscher</surname>, <given-names>M. T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nogaro S. I."><surname>Nogaro</surname>, <given-names>S. I.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Riley E. M."><surname>Riley</surname>, <given-names>E. M.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Walther M."><surname>Walther</surname>, <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-38">Comparison of parasite sequestration in uncomplicated and severe childhood Plasmodium falciparum malaria</article-title>. <source hwp:id="source-37">J Infect</source> <volume>67</volume>, <fpage>220</fpage>–<lpage>230</lpage> (<year>2013</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1 xref-ref-38-2"><label>38</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Dondorp A. M."><surname>Dondorp</surname>, <given-names>A. M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-39">Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2</article-title>. <source hwp:id="source-38">PLoS medicine</source> <volume>2</volume>, <fpage>e204</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.0020204</pub-id> (<year>2005</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>39</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Griffin J. T."><surname>Griffin</surname>, <given-names>J. T.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-40">Gradual acquisition of immunity to severe malaria with increasing exposure</article-title>. <source hwp:id="source-39">Proc Biol Sci</source> <volume>282</volume>, doi:<pub-id pub-id-type="doi">10.1098/rspb.2014.2657</pub-id> (<year>2015</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1 xref-ref-40-2"><label>40</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Walther M."><surname>Walther</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-41">HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children</article-title>. <source hwp:id="source-40">PLoS Pathog</source> <volume>8</volume>, <fpage>e1002579</fpage>, doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1002579</pub-id> (<year>2012</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1 xref-ref-41-2 xref-ref-41-3 xref-ref-41-4"><label>41</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Walther M."><surname>Walther</surname>, <given-names>M.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-42">Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria</article-title>. <source hwp:id="source-41">PLoS Pathog</source> <volume>5</volume>, <fpage>e1000364</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1000364</pub-id> (<year>2009</year>).</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>42</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Marsh K."><surname>Marsh</surname>, <given-names>K.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-43">Indicators of life-threatening malaria in African children</article-title>. <source hwp:id="source-42">N Engl J Med</source> <volume>332</volume>, <fpage>1399</fpage>–<lpage>1404</lpage> (<year>1995</year>).</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><label>43</label><citation publication-type="other" citation-type="journal" ref:id="321463v1.43" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-43"><collab hwp:id="collab-1">R Development Core Team</collab>. <source hwp:id="source-43">R: A language and environment for statistical computing. R Foundation for Statistical Computing</source>, &lt;URL <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.R–project.org/" ext-link-type="uri" xlink:href="http://www.R–project.org/" hwp:id="ext-link-6">http://www.R–project.org/</ext-link>&gt; (<year>2014</year>).</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1 xref-ref-44-2"><label>44</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Wood S. N."><surname>Wood</surname>, <given-names>S. N.</given-names></string-name> <article-title hwp:id="article-title-44">Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models</article-title>. <source hwp:id="source-44">J R Stat Soc B</source> <volume>73</volume>, <fpage>3</fpage>–<lpage>36</lpage> (<year>2011</year>).</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>45</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Dobin A."><surname>Dobin</surname>, <given-names>A.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-45">STAR: ultrafast universal RNA-seq aligner</article-title>. <source hwp:id="source-45">Bioinformatics</source> <volume>29</volume>, <fpage>15</fpage>–<lpage>21</lpage> (<year>2013</year>).</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="DeLuca D. S."><surname>DeLuca</surname>, <given-names>D. S.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-46">RNA-SeQC: RNA-seq metrics for quality control and process optimization</article-title>. <source hwp:id="source-46">Bioinformatics</source> <volume>28</volume>, <fpage>1530</fpage>–<lpage>1532</lpage> (<year>2012</year>).</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>47</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Anders S."><surname>Anders</surname>, <given-names>S.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pyl P. T."><surname>Pyl</surname>, <given-names>P. T.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Huber W."><surname>Huber</surname>, <given-names>W.</given-names></string-name> <article-title hwp:id="article-title-47">HTSeq--a Python framework to work with high-throughput sequencing data</article-title>. <source hwp:id="source-47">Bioinformatics</source> <volume>31</volume>, <fpage>166</fpage>–<lpage>169</lpage> (<year>2015</year>).</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><label>48</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Robinson M. D."><surname>Robinson</surname>, <given-names>M. D.</given-names></string-name>, <string-name name-style="western" hwp:sortable="McCarthy D. J."><surname>McCarthy</surname>, <given-names>D. J.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Smyth G. K."><surname>Smyth</surname>, <given-names>G. K.</given-names></string-name> <article-title hwp:id="article-title-48">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source hwp:id="source-48">Bioinformatics</source> <volume>26</volume>, <fpage>139</fpage>–<lpage>140</lpage> (<year>2010</year>).</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>49</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Chikina M."><surname>Chikina</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zaslavsky E."><surname>Zaslavsky</surname>, <given-names>E.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Sealfon S. C."><surname>Sealfon</surname>, <given-names>S. C.</given-names></string-name> <article-title hwp:id="article-title-49">CellCODE: a robust latent variable approach to differential expression analysis for heterogeneous cell populations</article-title>. <source hwp:id="source-49">Bioinformatics</source> <volume>31</volume>, <fpage>1584</fpage>–<lpage>1591</lpage> (<year>2015</year>).</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><label>50</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Abbas A. R."><surname>Abbas</surname>, <given-names>A. R.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-50">Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data</article-title>. <source hwp:id="source-50">Genes Immun</source> <volume>6</volume>, <fpage>319</fpage>–<lpage>331</lpage> (<year>2005</year>).</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><label>51</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Supek F."><surname>Supek</surname>, <given-names>F.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bosnjak M."><surname>Bosnjak</surname>, <given-names>M.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Skunca N."><surname>Skunca</surname>, <given-names>N.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Smuc T."><surname>Smuc</surname>, <given-names>T.</given-names></string-name> <article-title hwp:id="article-title-51">REVIGO summarizes and visualizes long lists of gene ontology terms</article-title>. <source hwp:id="source-51">PLoS One</source> <volume>6</volume>, <fpage>e21800</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id> (<year>2011</year>).</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><label>52</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Trager W."><surname>Trager</surname>, <given-names>W.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Jensen J. B."><surname>Jensen</surname>, <given-names>J. B.</given-names></string-name> <article-title hwp:id="article-title-52">Human malaria parasites in continuous culture</article-title>. <source hwp:id="source-52">Science</source> <volume>193</volume>, <fpage>673</fpage>–<lpage>675</lpage> (<year>1976</year>).</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1 xref-ref-53-2"><label>53</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Maier A. G."><surname>Maier</surname>, <given-names>A. G.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Rug M."><surname>Rug</surname>, <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-53">In vitro culturing Plasmodium falciparum erythrocytic stages</article-title>. <source hwp:id="source-53">Methods Mol Biol</source> <volume>923</volume>, <fpage>3</fpage>–<lpage>15</lpage> (<year>2013</year>).</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><label>54</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Dluzewski A. R."><surname>Dluzewski</surname>, <given-names>A. R.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ling I. T."><surname>Ling</surname>, <given-names>I. T.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rangachari K."><surname>Rangachari</surname>, <given-names>K.</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bates P. A."><surname>Bates</surname>, <given-names>P. A.</given-names></string-name> &amp; <string-name name-style="western" hwp:sortable="Wilson R. J."><surname>Wilson</surname>, <given-names>R. J.</given-names></string-name> <article-title hwp:id="article-title-54">A simple method for isolating viable mature parasites of Plasmodium falciparum from cultures</article-title>. <source hwp:id="source-54">Trans R Soc Trop Med Hyg</source> <volume>78</volume>, <fpage>622</fpage>–<lpage>624</lpage> (<year>1984</year>).</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><label>55</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Ribaut C."><surname>Ribaut</surname>, <given-names>C.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-55">Concentration and purification by magnetic separation of the erythrocytic stages of all human Plasmodium species</article-title>. <source hwp:id="source-55">Malar J</source> <volume>7</volume>, <fpage>45</fpage>, doi:<pub-id pub-id-type="doi">10.1186/1475-2875-7-45</pub-id> (<year>2008</year>).</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><label>56</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Malleret B."><surname>Malleret</surname>, <given-names>B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-56">A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development</article-title>. <source hwp:id="source-56">Sci Rep</source> <volume>1</volume>, <fpage>118</fpage>, doi:<pub-id pub-id-type="doi">10.1038/srep00118</pub-id> (<year>2011</year>).</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><label>57</label><citation publication-type="journal" citation-type="journal" ref:id="321463v1.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Pouw R. B."><surname>Pouw</surname>, <given-names>R. B.</given-names></string-name> <etal>et al.</etal> <article-title hwp:id="article-title-57">Complement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3</article-title>. <source hwp:id="source-57">PLoS One</source> <volume>11</volume>, <fpage>e0152164</fpage>, doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0152164</pub-id> (<year>2016</year>).</citation></ref></ref-list><ack hwp:id="ack-1"><title hwp:id="title-29">Acknowledgments</title><p hwp:id="p-51">We are grateful to Klaus Dietz for providing the original data and parameter estimates from malariatherapy patients and his model; to subjects who donated samples; to staff at MRC Gambia Unit for collection of samples; and to the St. Mary’s NHLI FACS core facility and Yanping Guo for support and instrumentation. <bold>Funding</bold>: This work was supported by the Medical Research Council (MRC) UK via core funding to the malaria research programme at the MRC Unit, The Gambia, and MRC Clinical Research Fellowships (G0701427 and MR/L006529/1) to A.J.C.; by a Wellcome Trust Value In People Award to A.J.C; and by European Union’s seventh Framework program under EC-GA no. 279185 (EUCLIDS; <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.euclids-project.eu" ext-link-type="uri" xlink:href="http://www.euclids-project.eu" hwp:id="ext-link-7">www.euclids-project.eu</ext-link>). <bold>Author contributions</bold>: A.J.C., A.G., A.E.vB., F.F., D.J.C., D.N., and M.W. collected the data used in the study; A.J.C., E.M.R., M.T.B., M.W. and D.J.C designed the study; U.D’A. and D.N. provided access to facilities and samples; A.J.C. and M.T.B. developed the mathematical model; A.J.C., A.G., M.T.B., H.J.L., F.F., and A.E.vB. analysed the data; D.W., T.W.K, D.N., U.D’A.,E.M.R., M.L., L.J.C., D.J.C., and A.J.C supervised aspects of the project; all authors contributed to interpretation of the results and drafting the manuscript. <bold>Competing interests</bold>: The authors declare that they have no competing financial interests.</p></ack></back></article>
